288 related articles for article (PubMed ID: 37178364)
1. Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study.
Kazmi N; Valeeva EV; Khasanova GR; Lewis SJ; Plotnikov D;
Cancer Causes Control; 2023 Aug; 34(8):725-734. PubMed ID: 37178364
[TBL] [Abstract][Full Text] [Related]
2. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
Lian J; Shi X; Jia X; Fan J; Wang Y; Zhao Y; Yang Y
J Hypertens; 2023 Jan; 41(1):44-50. PubMed ID: 36129112
[TBL] [Abstract][Full Text] [Related]
3. Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study.
Ardissino M; Slob EAW; Rajasundaram S; Reddy RK; Woolf B; Girling J; Johnson MR; Ng FS; Gill D
BMC Med; 2022 Sep; 20(1):288. PubMed ID: 36064525
[TBL] [Abstract][Full Text] [Related]
4. Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer's disease: a Mendelian randomization study.
Ou YN; Yang YX; Shen XN; Ma YH; Chen SD; Dong Q; Tan L; Yu JT
Alzheimers Res Ther; 2021 Feb; 13(1):41. PubMed ID: 33563324
[TBL] [Abstract][Full Text] [Related]
5. Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation.
Hyman MC; Levin MG; Gill D; Walker VM; Georgakis MK; Davies NM; Marchlinski FE; Damrauer SM
Hypertension; 2021 Feb; 77(2):376-382. PubMed ID: 33390040
[TBL] [Abstract][Full Text] [Related]
6. Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study.
Fan B; Schooling CM; Zhao JV
J Hum Hypertens; 2023 Nov; 37(11):1028-1032. PubMed ID: 37117874
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization does not support serum calcium in prostate cancer risk.
Yarmolinsky J; Berryman K; Langdon R; Bonilla C; ; Davey Smith G; Martin RM; Lewis SJ
Cancer Causes Control; 2018 Nov; 29(11):1073-1080. PubMed ID: 30306355
[TBL] [Abstract][Full Text] [Related]
8. Estimating the Population Benefits of Blood Pressure Lowering: A Wide-Angled Mendelian Randomization Study in UK Biobank.
Higgins H; Mason AM; Larsson SC; Gill D; Langenberg C; Burgess S
J Am Heart Assoc; 2021 Sep; 10(17):e021098. PubMed ID: 34459231
[TBL] [Abstract][Full Text] [Related]
9. The effects of blood pressure and antihypertensive drugs on heart failure: A Mendelian randomization study.
Li Y; Xiao W; Huang N; Zhuang Z; Zhang L; Wang W; Song Z; Zhao Y; Dong X; Xu M; Huang T
Nutr Metab Cardiovasc Dis; 2023 Jul; 33(7):1420-1428. PubMed ID: 37156668
[TBL] [Abstract][Full Text] [Related]
10. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
11. Assessing the role of blood pressure in amyotrophic lateral sclerosis: a Mendelian randomization study.
Xia K; Zhang L; Tang L; Huang T; Fan D
Orphanet J Rare Dis; 2022 Feb; 17(1):56. PubMed ID: 35172853
[TBL] [Abstract][Full Text] [Related]
12. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.
Bonilla C; Lewis SJ; Martin RM; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; Lathrop M; Davey Smith G;
BMC Med; 2016 Apr; 14():66. PubMed ID: 27044414
[TBL] [Abstract][Full Text] [Related]
13. Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study.
Jiang X; Dimou NL; Al-Dabhani K; Lewis SJ; Martin RM; Haycock PC; Gunter MJ; Key TJ; Eeles RA; Muir K; Neal D; Giles GG; Giovannucci EL; Stampfer M; Pierce BL; Schildkraut JM; Warren Andersen S; Thompson D; Zheng W; Kraft P; Tsilidis KK;
Int J Epidemiol; 2019 Oct; 48(5):1416-1424. PubMed ID: 30597039
[TBL] [Abstract][Full Text] [Related]
14. Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian-randomization study based on 79 148 prostate-cancer cases and 61 106 controls.
Kazmi N; Haycock P; Tsilidis K; Lynch BM; Truong T; ; Martin RM; Lewis SJ
Int J Epidemiol; 2020 Apr; 49(2):587-596. PubMed ID: 31802111
[TBL] [Abstract][Full Text] [Related]
15. Genetically determined blood pressure, antihypertensive medications, and risk of intracranial aneurysms and aneurysmal subarachnoid hemorrhage: A Mendelian randomization study.
Liu H; Zuo H; Johanna O; Zhao R; Yang P; Chen W; Li Q; Lin X; Zhou Y; Liu J
Eur Stroke J; 2024 Mar; 9(1):244-250. PubMed ID: 37800876
[TBL] [Abstract][Full Text] [Related]
16. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.
Davies NM; Gaunt TR; Lewis SJ; Holly J; Donovan JL; Hamdy FC; Kemp JP; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Smith GD; Martin RM
Cancer Causes Control; 2015 Nov; 26(11):1603-16. PubMed ID: 26387087
[TBL] [Abstract][Full Text] [Related]
17. Association between blood pressure and different antihypertensive drugs with outcome after ischemic stroke: A Mendelian randomization study.
Liu H; Zhang X; Zhou Y; Nguyen TN; Zhang L; Xing P; Li Z; Shen H; Zhang Y; Hua W; Xu H; Zhu X; Chen L; Zuo Q; Zhao R; Li Q; Dai D; Zhang Y; Xu Y; Huang Q; Liu J; Yang P
Int J Stroke; 2023 Dec; 18(10):1247-1254. PubMed ID: 37337369
[TBL] [Abstract][Full Text] [Related]
18. Blood lipids and prostate cancer: a Mendelian randomization analysis.
Bull CJ; Bonilla C; Holly JM; Perks CM; Davies N; Haycock P; Yu OH; Richards JB; Eeles R; Easton D; Kote-Jarai Z; Amin Al Olama A; Benlloch S; Muir K; Giles GG; MacInnis RJ; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Micheal A; Pandha H; Smith GD; Lewis SJ; Martin RM;
Cancer Med; 2016 Jun; 5(6):1125-36. PubMed ID: 26992435
[TBL] [Abstract][Full Text] [Related]
19. Mendelian randomization analyses identified bioavailable testosterone mediates the effect of sex hormone-binding globulin on prostate cancer.
Wan B; Lu L; Lv C
Andrology; 2023 Sep; 11(6):1023-1030. PubMed ID: 36524281
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Antihypertensive and Statin Medications for Spinal Pain: A Mendelian Randomization Study.
Suri P; Elgaeva EE; Williams FMK; Freidin MB; Verzun DA; Tsepilov YA
Spine (Phila Pa 1976); 2023 Nov; 48(22):1568-1574. PubMed ID: 37539717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
